Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
12/2003
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490095A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6669937 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
12/30/2003US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/25/2003US20030236433 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
12/25/2003US20030236425 Ultraviolet radiation curable hot melt pressure sensitive adhesives, coatings and casings
12/25/2003US20030236414 A 5(S)-N-acetyl-2(R)-methyl-4- keto-6-phenyl hexanoate or hexanoic acid or derivatives, use as antibiotics, antibiotic enhancers, or enzyme inhibitors
12/25/2003US20030236304 Fluorobenzamides and uses thereof
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106403A1 Carboxamides derivatives
12/24/2003WO2003106380A2 Fluorobenzamides
12/24/2003WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667341 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters; anticancer agents, hemological disorders, and inherited metabolic disorders
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667284 A coverings on a magnetic head for reading and writing on a computer disk drives, audio and video equipment; wear resistance; a compound select from hydrocarbyl-substituted cyclopentanes, cyclopentenes or cyclopentadienes
12/18/2003WO2003104318A1 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof
12/18/2003WO2003103609A2 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/18/2003WO2003074474A3 Multiple-component solid phases containing at least one active pharmaceutical ingredient
12/18/2003WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003070689A3 Polymer bound donor-acceptor-donor compounds and their use in a 3-dimensional optical memory
12/18/2003WO2003048079A3 Method for the arylation of olefins
12/18/2003WO2003038523A3 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
12/18/2003WO2003033437A3 A method of forming neuraminidase inhibitors by dynamic combinatorial chemistry and compounds obtained
12/18/2003US20030232991 For use in asymmetric hydrogenation, hydride transfer, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, hydrocarboxylation, isomerization, allylic alkylation, cyclopropanation, Diels-Alder reaction, etc.
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232883 N-acylamino benzyl ether derivatives
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/18/2003CA2483141A1 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370516A2 Quaternary surfactants
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1278718B1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664412 Method for producing lysine derivative
12/16/2003US6664293 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
12/16/2003US6664291 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003US6663898 Carbon-substituted diketopiperazine delivery systems
12/16/2003US6663887 Compounds and compositions for delivering active agents
12/11/2003WO2003102069A1 ß CRYSTALINE POLYPROPYLENES
12/11/2003WO2003101945A1 Ligands that are inhibitors of the rar receptors
12/11/2003WO2003101937A1 Synthetic methods for the large scale production from glucose of analogs of sphingosine, azidosphingosine, ceramides, lactosyl ceramides, and glycosyl phytosphingosine
12/11/2003WO2003101935A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101381A2 1,2 diamido cycloalkyl sodium channel blockers
12/11/2003WO2003004460A3 Succinic acid derivatives
12/11/2003US20030229251 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
12/11/2003US20030229249 Low temperature drying of wet crystals; antidiabetic agents
12/11/2003US20030229144 Anti-epileptogenic agents
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030228986 Polyol ester derivatives of polyamines and use in turbine oils to improve cleanliness
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/10/2003EP1368310A2 Improved methods of ortho alkylation
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1130361C Process for producing isooxazolidinedione compound
12/10/2003CN1130124C Fungicidal mixtures
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660773 Reacting anisidine with 3-chloropropionamide to form N-(4-methoxy phenyl)-3-chloropropionamide; intramolecular Friedel-Crafts cyclization with a Lewis acid; decomposition of salt; demethylation
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660712 Stabilization of amido acids with antioxidants
12/04/2003WO2003099832A1 Hydroxy diphosphines and their use in catalysis
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003US20030225302 Aromatic amides, their preparation process and their use as pesticides
12/04/2003US20030225298 Reacting bis-(phosophonomethyl)urea or urea with carbon monoxide and formaldehyde in the presence of catalysts and solvents to form N-(phosphonomethyl)glycine
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030224006 A solid phase that is sustained by intermolecular interactions (hydrogen bonding) between two or more independent molecular entities, and at least one entity is a drug; improved drug solublity, stability, bioavailability
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 289